After five months of basic military training, the proportion of female recruits with iron deficiency had more than doubled, from 25% to 55%.
AstraZeneca’s Imfinzi increases survival rates in bladder cancer in pivotal study
BARCELONA, Spain — An AstraZeneca immunotherapy, given both before and after surgery, improved survival rates in patients with bladder cancer, results that could reshape how